2011
DOI: 10.1016/j.colsurfa.2011.03.006
|View full text |Cite
|
Sign up to set email alerts
|

Exothermic effect of dextran-coated Fe3O4 magnetic fluid and its compatibility with blood

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
3
0
1

Year Published

2012
2012
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 30 publications
1
3
0
1
Order By: Relevance
“…However, visual observation proves that BRCs do not coagulate, for example, at 0.32 mg/mL magnetite content (left side of Figure 8). Blood coagulation experiments have also been conducted by Liu and co-workers 62 (using dextran-coated MNPs), and they found the same level of resistance against similar magnetite concentrations as in our experiments.…”
Section: ■ Results and Discussionsupporting
confidence: 86%
“…However, visual observation proves that BRCs do not coagulate, for example, at 0.32 mg/mL magnetite content (left side of Figure 8). Blood coagulation experiments have also been conducted by Liu and co-workers 62 (using dextran-coated MNPs), and they found the same level of resistance against similar magnetite concentrations as in our experiments.…”
Section: ■ Results and Discussionsupporting
confidence: 86%
“…Our group has conducted research on the heating effect of Fe 3 O 4 magnetic fluid; the results demonstrated that the exothermic ability of magnetic fluid was excellent in an alternating magnetic field. 28 Magnetic fluid can be used for magnetic induction heating treatment of a tumor, one of the crucial factors is that the temperature used for cancer therapy should reach 44–47℃. In this section, the in vitro heating effect of the modified magnetic nanoparticles was evaluated systematically.…”
Section: Resultsmentioning
confidence: 99%
“…To resolve this challenge, polymeric and inorganic nanoparticles, liposomes, micelles and phospholipid complexes have been used to encapsulate them for delivery. Among them, polymeric nanoparticles are emerging as one of the best options due to their higher stability (Cole et al 2011a ; Lin et al 2012 ; Liu et al 2011 ; Rao et al 2013 ). The particles can be delivered to the tumor either passively thorough vascularization and the enhanced permeation and retention effect (EPR) or actively thorough receptor-mediated endocytosis.…”
Section: Introductionmentioning
confidence: 99%